{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:44:40Z","timestamp":1752230680174},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/spc.0000000000000014","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T12:58:07Z","timestamp":1382360287000},"page":"339-341","source":"Crossref","is-referenced-by-count":6,"title":["Anti-inflammatory therapy"],"prefix":"10.1097","volume":"7","author":[{"given":"Aminah","family":"Jatoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-2-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","article-title":"Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexiacachexia: a double-blind, placebo-controlled trial.","volume":"21","author":"Bruera","year":"2003","journal-title":"J Clin Oncol"},{"key":"R4-2-20211004","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol"},{"key":"R5-2-20211004","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.","volume":"22","author":"Jatoi","year":"2004","journal-title":"J Clin Oncol"},{"key":"R6-2-20211004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly andor poor performance nonsmall cell lung cancer patients (N01C9).","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"R7-2-20211004","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexiaweight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"R8-2-20211004","first-page":"5602","article-title":"Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.","volume":"54","author":"Lundholm","year":"1994","journal-title":"Cancer Res"},{"key":"R9-2-20211004","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAKSTAT signaling pathway.","volume":"117","author":"Rawlings","year":"2004","journal-title":"J Cell Sci"},{"key":"R10-2-20211004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.","volume":"366","author":"Versrovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"R11-2-20211004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients.","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"R13-2-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ejcn.1602682","article-title":"Effects of bovine serum concentrate, with or without supplemental micronutrients, on the growth, morbidity, and micronutrient status of young children in a low-income, peri-urban Guatemalan community.","volume":"62","author":"Begin","year":"2008","journal-title":"Eur J Clin Nutr"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:22:32Z","timestamp":1633501352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00002"}},"subtitle":["exploring exercise, serum-derived bovine immunoglobulin\/protein isolates, and ruxolitinib for the cancer-associated weight loss syndrome"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000014","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}